These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 2816989
1. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen. Steinmann B, Superti-Furga A, Joller-Jemelka HI, Cetta G, Byers PH. Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989 [Abstract] [Full Text] [Related]
2. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen. Utani A, Tanaka T, Nishigori C, Miyachi Y, Danno K, Imamura S, Hosokawa M, Takeda T, Hirayoshi K, Nagata K. Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725 [Abstract] [Full Text] [Related]
3. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV. Dyne KM, Zanaboni G, Annoni G, De Agostini MP, Cetta G. Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053 [Abstract] [Full Text] [Related]
5. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen. Pyeritz RE, Stolle CA, Parfrey NA, Myers JC. Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506 [Abstract] [Full Text] [Related]
7. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV. Thakker-Varia S, Anderson DW, Kuivaniemi H, Tromp G, Shin HG, van der Rest M, Glorieux FH, Ala-Kokko L, Stolle CA. Hum Mutat; 1995 Nov; 6(2):116-25. PubMed ID: 7581395 [Abstract] [Full Text] [Related]
9. [Serum type III procollagen N-terminal peptide in patients with collagen diseases]. Aoki A, Hagiwara E, Atsumi Y, Shirai A, Igarashi T, Narita M, Matsunaga K, Ishigatsubo Y, Tani K, Okubo T. Ryumachi; 1990 Apr; 30(2):81-4. PubMed ID: 2173157 [Abstract] [Full Text] [Related]
11. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy]. Niitsu N, Umeda M. Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840 [Abstract] [Full Text] [Related]
12. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I]. Sokolov BP, Sher BM, Lomova TIu, Kukharenko VI, Blinnikova OE. Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422 [Abstract] [Full Text] [Related]
13. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII. Ho KK, Kong RY, Kuffner T, Hsu LH, Ma L, Cheah KS. Hum Mutat; 1994 Jan; 3(4):358-64. PubMed ID: 8081389 [Abstract] [Full Text] [Related]
14. Periodontal Ehlers-Danlos syndrome associated with type III and I collagen deficiencies. Mataix J, Bañuls J, Muñoz C, Bermejo A, Climent JM. Br J Dermatol; 2008 Apr; 158(4):825-30. PubMed ID: 18284404 [Abstract] [Full Text] [Related]
15. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. Pasquali M, Still MJ, Vales T, Rosen RI, Evinger JD, Dembure PP, Longo N, Elsas LJ. Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914 [Abstract] [Full Text] [Related]